Journal of Biosciences

, 44:22 | Cite as

Emerging roles of long non-coding RNAs in cancer

  • Manjima Chatterjee
  • Sonali SenguptaEmail author


Cancer is a physiological condition that has both the endogenous and exogenous influences on its progression. It originates from unusual cell growth, where the cells undergo massive genetic alterations, bypass the signaling machinery and compromise its genetic cohesion. Literature has well narrated the DNA damage studies including driver mutations that interfere with the treatment strategies. However, with evolving medical excellence, recent day studies are trying to unveil the contribution of RNAs in the progression of tumor malignancies. A number of non-coding RNAs have been identified as an active component in cancer genomics. This article aims to review the role of long non-coding RNAs in the spectra of cancers and its prognostic value as the biomarkers in molecular targeting with clinical utility and therapeutic beneficence.


Biomarkers cancers DNA damages genetic assaults long non-coding RNAs therapeutics 



  1. Adams BD, Anastasiadou E, Esteller M, He L and Slack FJ 2015 The inescapable influence of noncoding RNAs in cancer. Cancer Res. 75 5206–5210PubMedPubMedCentralGoogle Scholar
  2. Aird J, Baird AM, Lim MC, McDermott R, Finn SP and Gray SG 2018 Carcinogenesis in prostate cancer: the role of long non-coding RNAs. Non-coding RNA Res. 3 29–38Google Scholar
  3. Alves IT, Hiltemann S, Hartjes T, van der Spek P, Stubbs A, Trapman J and Jenster G 2013 Gene fusions by chromothripsis of chromosome 5q in the VCaP prostate cancer cell line. Hum. Genet. 132 709–713Google Scholar
  4. Anastasiadou E, Jacob LS and Slack FJ 2018 Non-coding RNA networks in cancer. Nat. Rev. Cancer 18 5PubMedGoogle Scholar
  5. Balas MM and Johnson AM 2018 Exploring the mechanisms behind long noncoding RNAs and cancer. Non-coding RNA Res. (in press)Google Scholar
  6. Bartonicek N, Maag JL and Dinger ME 2016 Long noncoding RNAs in cancer: mechanisms of action and technological advancements. Mol. Cancer 15 43PubMedPubMedCentralGoogle Scholar
  7. Beckedorff FC, Amaral MS, Deocesano-Pereira C and Verjovski-Almeida S 2013 Long non-coding RNAs and their implications in cancer epigenetics. Biosci. Rep. 33 e00061PubMedPubMedCentralGoogle Scholar
  8. Berger MF, Lawrence MS, Demichelis F, Drier Y, Cibulskis K, Sivachenko AY, Sboner A, Esgueva R, et al. 2011 The genomic complexity of primary human prostate cancer. Nature 470 214PubMedPubMedCentralGoogle Scholar
  9. Bertrand C 2014 Long non-coding RNAs in cancer: the role of HOTAIR in epithelial-to-mesenchymal transition, PhD thesis, Université Pierre et Marie Curie-Paris VIGoogle Scholar
  10. Bhan A and Mandal SS 2016 Estradiol-Induced Transcriptional Regulation of Long Non-Coding RNA, HOTAIR; in Estrogen Receptors. Methods in Molecular Biology (ed) KM Eyster (Humana Press, New York, NY) vol 1366Google Scholar
  11. Bhan A, Hussain I, Ansari KI, Kasiri S, Bashyal A and Mandal SS 2013 Antisense transcript long noncoding RNA (lncRNA) HOTAIR is transcriptionally induced by estradiol. J Mol. Biol. 425 3707–3722PubMedPubMedCentralGoogle Scholar
  12. Bhat SA, Ahmad SM, Mumtaz PT, Malik AA, Dar MA, Urwat U, Shah RA and Ganai NA 2016 Long non-coding RNAs: mechanism of action and functional utility. Non-coding RNA Res. 1 43–50Google Scholar
  13. Bijnsdorp IV, van Royen ME, Verhaegh GW and Martens-Uzunova ES 2017 The non-coding transcriptome of prostate cancer: implications for clinical practice. Mol. Diagn. Ther. 21 1–16Google Scholar
  14. Cai Q, Wang Z, Wang S, Weng M, Zhou D, Li C, Wang J, Chen E, et al. 2017 Long non-coding RNA LINC00152 promotes gallbladder cancer metastasis and epithelial–mesenchymal transition by regulating HIF-1α via miR-138. Open Biol. 7 160247PubMedPubMedCentralGoogle Scholar
  15. Caslini C, Connelly JA, Serna A, Broccoli D and Hess JL 2009 MLL associates with telomeres and regulates telomeric repeat-containing RNA transcription. Mol. Cell Biol. 29 4519–4526PubMedPubMedCentralGoogle Scholar
  16. Cerk S, Schwarzenbacher D, Adiprasito JB, Stotz M, Hutterer GC, Gerger A, Ling H, Calin GA, et al. 2016 Current status of long non-coding RNAs in human breast cancer. Int. J. Mol. Sci. 17 1485PubMedCentralGoogle Scholar
  17. Chatterjee M, Chinder P, Mannan AU, Sheela ML, Mukherjee U, Choudhury S, Lo C, Singh S et al. 2016 Genotype-phenotype analysis in an indian Family affected with Li-Fraumeni syndrome-role of genetic counselling. Int. J. Hum. Genet. 16 98–106Google Scholar
  18. Chatterjee M, Sheela ML, Mukherjee U, Patil S, Satheesh CT, Murugan K, Naik R, Rao N et al. 2016 Incidental findings in male breast carcinoma: a genetic counseling approach. Int. J. Hum. Genet. 16 120–127Google Scholar
  19. Chen B, Yu M, Chang Q, Lu Y, Thakur C, Ma D, Yi Z and Chen F 2013 Mdig de-represses H19 large intergenic non-coding RNA (lincRNA) by down-regulating H3K9me3 and heterochromatin. Oncotarget 4 1427PubMedPubMedCentralGoogle Scholar
  20. Chen D, Sun Q, Cheng X, Zhang L, Song W, Zhou D, Lin J and Wang W 2016 Genome‐wide analysis of long noncoding RNA (lncRNA) expression in colorectal cancer tissues from patients with liver metastasis. Cancer Med. 5 1629–1639PubMedPubMedCentralGoogle Scholar
  21. Chen J, Liu S and Hu X 2018 Long non-coding RNAs: crucial regulators of gastrointestinal cancer cell proliferation. Cell Death Dis. 4 50Google Scholar
  22. Cheng Z and Mao H 2017 Long Non-Coding RNA in Non-Small Cell Lung Cancers; in A Global Scientific Vision-Prevention, Diagnosis, and Treatment of Lung Cancer (ed) Marta Adonis InTech.
  23. Collette J, Le Bourhis X and Adriaenssens E 2017 Regulation of human breast Cancer by the long non-coding RNA H19. Int. J. Mol. Sci. 18 2319PubMedCentralGoogle Scholar
  24. Deng, R, Liu B, Wang Y, Yan F, Hu S, Wang H, Wang T, Li B et al. 2016 High expression of the newly found long noncoding RNA Z38 promotes cell proliferation and oncogenic activity in breast cancer. J. Cancer 7 576PubMedPubMedCentralGoogle Scholar
  25. Fan Y, Shen B, Tan M, Mu X, Qin Y, Zhang F and Liu Y 2014 Long non‐coding RNA UCA1 increases chemoresistance of bladder cancer cells by regulating Wnt signaling. FEBS J. 281 1750–1758PubMedGoogle Scholar
  26. Fang TT, Sun XJ, Chen J, Zhao Y, Sun RX, Ren N and Liu BB 2014. Long non-coding RNAs are differentially expressed in hepatocellular carcinoma cell lines with differing metastatic potential. Asia. Pac. J. Cancer Prev. 15 10513–10524Google Scholar
  27. Feng L, Wang R, Lian M, Ma H, He N, Liu H, Wang H and Fang J 2016 Integrated analysis of long noncoding RNA and mRNA expression profile in advanced laryngeal squamous cell carcinoma. PLoS ONE 11 e0169232PubMedPubMedCentralGoogle Scholar
  28. Ferlay J, Shin HR, Bray F, Forman D, Mathers C and Parkin DM 2010 Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int. J. Cancer 127 2893–2917PubMedGoogle Scholar
  29. Fitzmaurice C, Dicker D, Pain A, Hamavid H, Moradi-Lakeh M, MacIntyre MF, Allen C, Hansen G et al. 2015 The global burden of cancer 2013. JAMA Oncol. 1 505–527PubMedGoogle Scholar
  30. Glover AR, Zhao JT, Ip JC, Lee JC, Robinson BG, Gill AJ, Soon PSH and Sidhu SB 2015 Long noncoding RNA profiles of adrenocortical cancer can be used to predict recurrence. Endocr.-Relat. Cancer. 22 99–109PubMedGoogle Scholar
  31. Goenka A, Sengupta S, Pandey R, Parihar R, Mohanta GC, Mukerji M and Ganesh S 2016 Human satellite-III non-coding RNAs modulate heat-shock-induced transcriptional repression. J. Cell Sci. 129 3541–3552PubMedGoogle Scholar
  32. Holliday DL and Speirs V 2011 Choosing the right cell line for breast cancer research. Breast Cancer Res. 13 215PubMedPubMedCentralGoogle Scholar
  33. Hong S, Kim T, Sung KB, Kim P, Ha H, Kim A and Lee MG 2003 Extrahepatic spread of hepatocellular carcinoma: a pictorial review. Eur. Rradiol. 13 874–882Google Scholar
  34. Hu X, Bao J, Wang Z, Zhang Z, Gu P, Tao F, Cui D and Jiang W 2016 The plasma lncRNA acting as fingerprint in non-small-cell lung cancer. Tumor Biol. 37 3497–3504Google Scholar
  35. Huarte M, Guttman M, Feldser D, Garber M, Koziol MJ, Kenzelmann-Broz D, Khalil AM, Zuk O et al. 2010. A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response. Cell 142 409–419PubMedPubMedCentralGoogle Scholar
  36. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D 2011 Global cancer statistics. CA Cancer J. Clin. 61 69–90PubMedPubMedCentralGoogle Scholar
  37. Ji TT, Huang X, Jin J, Pan SH and Zhuge XJ 2016 Inhibition of long non-coding RNA TUG1 on gastric cancer cell transference and invasion through regulating and controlling the expression of miR-144/c-Met axis. Asia. Pac. J. Trop. Med. 9 508–512Google Scholar
  38. Jiang HJ, Wang S and Ding Y 2014 Emerging paradigms of long non-coding RNAs in gastrointestinal cancer. Am. J. Stem Cells. 3 63PubMedPubMedCentralGoogle Scholar
  39. Kaplan R, Luettich K, Heguy A, Hackett NR, Harvey BG and Crystal RG 2003 Monoallelic up-regulation of the imprinted H19 gene in airway epithelium of phenotypically normal cigarette smokers. Cancer Res. 63 1475–1482PubMedGoogle Scholar
  40. Ke K, Sun Z and Wang Z 2018 Downregulation of long non-coding RNA GAS5 promotes cell proliferation, migration and invasion in esophageal squamous cell carcinoma. Oncol. Lett. 16 1801–1808PubMedPubMedCentralGoogle Scholar
  41. Leygue E, Dotzlaw H, Watson PH and Murphy LC 1999 Expression of the steroid receptor RNA activator in human breast tumors. Cancer Res. 59 4190–4193PubMedGoogle Scholar
  42. Li C, Yang L and Lin C 2014 Long noncoding RNAs in prostate cancer: mechanisms and applications. Mol. Cell. Oncol. 1 e963469PubMedPubMedCentralGoogle Scholar
  43. Li SQ, Li F, Xiao Y, Wang CM, Tuo L, Hu J, Yang XB, Wang JS, et al. 2014 Comparison of long non-coding RNAs, microRNAs and messenger RNAs involved in initiation and progression of esophageal squamous cell carcinoma. Mol. Med. Rep. 10 652–662PubMedPubMedCentralGoogle Scholar
  44. Li J, Wang Y, Yu J, Dong R and Qiu H 2015 A high level of circulating HOTAIR is associated with progression and poor prognosis of cervical cancer. Tumor Biol. 36 1661–1665Google Scholar
  45. Li W, Zhai L, Wang H, Liu C, Zhang J, Chen W and Wei Q 2016 Downregulation of LncRNA GAS5 causes trastuzumab resistance in breast cancer. Oncotarget. 7 27778PubMedPubMedCentralGoogle Scholar
  46. Li J, Liu Y, Li P, Guo Y, Liu Y and Ren Y 2017 Long noncoding RNA CCAT2 promotes proliferation and metastasis in non-small cell lung cancer through the Wnt pathway. Int. J. Clin. Exp. Pathol. 10 7983–7990Google Scholar
  47. Lin CP and He L 2017 Noncoding RNAs in cancer development. Annu. Rev. Cancer Biol. 1 163–84Google Scholar
  48. Liu XH, Liu ZL, Sun M, Liu J, Wang ZX and De W 2013 The long non-coding RNA HOTAIR indicates a poor prognosis and promotes metastasis in non-small cell lung cancer. BMC Cancer 13 464PubMedPubMedCentralGoogle Scholar
  49. Liu Z, Sun M, Lu K, Liu J, Zhang M, Wu W, De W, Wang Z et al. 2013 The long noncoding RNA HOTAIR contributes to cisplatin resistance of human lung adenocarcinoma cells via downregualtion of p21WAF1/CIP1 expression. PLoS ONE 8 e77293PubMedPubMedCentralGoogle Scholar
  50. Llovet JM, Lencioni R, Gaile PR et al. 2012 EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 56 908–43Google Scholar
  51. Luo X, Qiu Y, Jiang Y, Chen F, Jiang L, Zhou Y, Dan H, Zeng X et al. 2018 Long non-coding RNA implicated in the invasion and metastasis of head and neck cancer: possible function and mechanisms. Mol. Cancer 17 14PubMedPubMedCentralGoogle Scholar
  52. Lv M, Xu P, Wu Y, Huang L, Li W, Lv S, Wu X, Zeng X, et al. 2016 LncRNAs as new biomarkers to differentiate triple negative breast cancer from non-triple negative breast cancer. Oncotarget. 7 13047PubMedPubMedCentralGoogle Scholar
  53. Ma Y, Yang Y, Wang F, Moyer MP, Wei Q, Zhang P, Yang Z, Liu W, et al. 2016 Long non-coding RNA CCAL regulates colorectal cancer progression by activating Wnt/β-catenin signaling pathway via suppression of activator protein 2α. Gut 65 1494–1504 PubMedGoogle Scholar
  54. Malik B and Feng FY 2016 Long noncoding RNAs in prostate cancer: overview and clinical implications. Asia. J. Androl. 18 568Google Scholar
  55. Martens-Uzunova ES, Böttcher R, Croce CM, Jenster G, Visakorpi T and Calin GA 2014 Long noncoding RNA in prostate, bladder, and kidney cancer. Eur. Urol. 65 1140–1151PubMedGoogle Scholar
  56. Matouk IJ, Mezan S, Mizrahi A, Ohana P, Abu-lail R, Fellig Y, Galun E and Hochberg A 2010 The oncofetal H19 RNA connection: hypoxia, p53 and cancer. Biochim. Biophys. Acta (BBA)-Mol. Cell Res. 1803 443–451Google Scholar
  57. Mitra R, Chen X, Greenawalt EJ, Maulik U, Jiang W, Zhao Z and Eischen CM 2017 Decoding critical long non-coding RNA in ovarian cancer epithelial-to-mesenchymal transition. Nat. Commun. 8 1604PubMedPubMedCentralGoogle Scholar
  58. Ong MS, Cai W, Tan TZ, Huang RYJ, Hooi SC, Yap CT and Kumar AP 2018 Long non-coding RNA landscape in colorectal cancer. RNA Dis. 5 e1628Google Scholar
  59. Palazzo AF and Lee ES 2015 Non-coding RNA: what is functional and what is junk? Front. Genet. 6 2PubMedPubMedCentralGoogle Scholar
  60. Paralkar VR and Weiss MJ 2013 Long noncoding RNAs in biology and hematopoiesis. Blood 121 4842–4846PubMedPubMedCentralGoogle Scholar
  61. Park SM, Park SJ, Kim HJ, Kwon OH, Kang TW, Sohn HA, Kim SK, Noh SM et al. 2013 A known expressed sequence tag, BM742401, is a potent lincRNA inhibiting cancer metastasis. Exp. Mol. Med. 45 e31PubMedPubMedCentralGoogle Scholar
  62. Peng WX, Koirala P and Mo YY 2017 LncRNA-mediated regulation of cell signaling in cancer. Oncogene 36 5661-5667PubMedPubMedCentralGoogle Scholar
  63. Peter S, Borkowska E, Drayton RM, Rakhit CP, Noon AP, Chen W and Catto JW 2014 Identification of differentially expressed long non-coding RNAs in bladder cancer. Clin. Cancer. Res. 20 5311–5321PubMedGoogle Scholar
  64. Poliseno L, Salmena L, Zhang J, Carver B, Haveman WJ and Pandolfi PP 2010 A coding-independent function of gene and pseudogene mRNAs regulates tumor biology. Nature 465 1033PubMedPubMedCentralGoogle Scholar
  65. Pop-Bica C, Gulei D, Cojocneanu-Petric R, Braicu C, Petrut B and Berindan-Neagoe I 2017 Understanding the role of non-coding rnas in bladder cancer: From dark matter to valuable therapeutic targets. Int. J. Mol. Sci. 18 1514PubMedCentralGoogle Scholar
  66. Prensner JR, Iyer MK, Balbin OA, Dhanasekaran SM, Cao Q, Brenner JC, Laxman B, Asangani IA, et al. 2011 Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progression. Nat. Biotechnol. 29 742–749PubMedPubMedCentralGoogle Scholar
  67. Prensner JR, Zhao S, Erho N, Schipper M, Iyer MK, Dhanasekaran SM, Magi-Galluzzi C, Mehra R et al. 2014 RNA biomarkers associated with metastatic progression in prostate cancer: a multi-institutional high-throughput analysis of SChLAP1. Lancet Oncol. 15 1469–1480.PubMedPubMedCentralGoogle Scholar
  68. Qi P and Du X 2013 The long non-coding RNAs, a new cancer diagnostic and therapeutic gold mine. Mod. Pathol. 26 155–165PubMedGoogle Scholar
  69. Qi P, Zhou XY and Du X 2016 Circulating long non-coding RNAs in cancer: current status and future perspectives. Mol. Cancer. 15 39PubMedPubMedCentralGoogle Scholar
  70. Rangel LB, Sherman-Baust CA, Wernyj RP, Schwartz DR, Cho KR and Morin PJ 2003 Characterization of novel human ovarian cancer-specific transcripts (HOSTs) identified by serial analysis of gene expression. Oncogene 22 7225PubMedGoogle Scholar
  71. Redis RS, Sieuwerts AM, Look MP, Tudoran O, Ivan C, Spizzo R, Zhang X, de Weerd V et al. 2013 CCAT2, a novel long non-coding RNA in breast cancer: expression study and clinical correlations. Oncotarget 4 1748PubMedPubMedCentralGoogle Scholar
  72. Ren S, Liu Y, Xu W, Sun Y, Lu J, Wang F, Wei M, Shen J et al. 2013 Long noncoding RNA MALAT-1 is a new potential therapeutic target for castration resistant prostate cancer. J. Urol. 190 2278–2287PubMedGoogle Scholar
  73. Sahu A, Singhal U and Chinnaiyan AM 2015 Long noncoding RNAs in cancer: from function to translation. Trends Cancer 1 93–109PubMedPubMedCentralGoogle Scholar
  74. Sampl S, Pramhas S, Stern C, Preusser M, Marosi C and Holzmann K 2012 Expression of telomeres in astrocytoma WHO grade 2 to 4: TERRA level correlates with telomere length, telomerase activity, and advanced clinical grade. Transl. Oncol. 5 56IN1–65IN4PubMedPubMedCentralGoogle Scholar
  75. Sengupta S, Parihar R and Ganesh S 2009 Satellite III non-coding RNAs show distinct and stress-specific patterns of induction. Biochem. Biophys. Res. Commun. 382 102–107PubMedGoogle Scholar
  76. Shen MM 2013 Chromoplexy: a new category of complex rearrangements in the cancer genome. Cancer Cell 23 567–569PubMedPubMedCentralGoogle Scholar
  77. Shen X, Xie B, Ma Z, Yu W, Wang W, Xu D, Yan X, Chen B et al. 2015 Identification of novel long non-coding RNAs in triple-negative breast cancer. Oncotarget 6 21730PubMedPubMedCentralGoogle Scholar
  78. Song H, Sun W, Ye G, Ding X, Liu Z, Zhang S, Xia T, Xiao B et al. 2013 Long non-coding RNA expression profile in human gastric cancer and its clinical significances. J. Transl. Med. 11 225PubMedPubMedCentralGoogle Scholar
  79. Song W, Sun Y, Lin J and Bi X 2018 Current research on head and neck cancer-associated long noncoding RNAs. Oncotarget 9 1403PubMedGoogle Scholar
  80. Soudyab M, Iranpour M and Ghafouri-Fard S 2016 The role of long non-coding RNAs in breast cancer. Arch. Iran. Med. (AIM) 19 508–517Google Scholar
  81. Stewart BWKP and Wild CP 2017 World cancer report 2014. Health Google Scholar
  82. Su X, Li G and Liu W 2017 The long noncoding RNA cancer susceptibility candidate 9 promotes nasopharyngeal carcinogenesis via stabilizing HIF1α. DNA Cell. Biol. 36 394–400PubMedGoogle Scholar
  83. Su F, He W, Chen C, Liu M, Liu H, Xue F, Bi J, Xu D et al. 2018 The long non-coding RNA FOXD2-AS1 promotes bladder cancer progression and recurrence through a positive feedback loop with Akt and E2F1. Cell Death Dis. 9 233PubMedPubMedCentralGoogle Scholar
  84. Sun W, Wu Y, Yu X, Liu Y, Song H, Xia T, Xiao B and Guo J 2013 Decreased expression of long noncoding RNA AC096655. 1–002 in gastric cancer and its clinical significance. Tumor Biol. 34 2697–2701Google Scholar
  85. Tang J, Jiang R, Deng L, Zhang X, Wang K, Sun B 2015 Circulation long non-coding RNAs act as biomarkers for predicting tumorigenesis and metastasis in hepatocellular carcinoma. Oncotarget 6 4505PubMedPubMedCentralGoogle Scholar
  86. Tong YS, Wang XW, Zhou XL, Liu ZH, Yang TX, Shi WH, Xie HW, Lv J et al. 2015 Identification of the long non-coding RNA POU3F3 in plasma as a novel biomarker for diagnosis of esophageal squamous cell carcinoma. Mol. Cancer. 14 3PubMedPubMedCentralGoogle Scholar
  87. Tripathi V, Ellis JD, Shen Z, Song DY, Pan Q, Watt AT, Freier SM, Bennett CF et al. 2010 The nuclear-retained noncoding RNA MALAT1 regulates alternative splicing by modulating SR splicing factor phosphorylation. Mol. Cell. 39 925–938PubMedPubMedCentralGoogle Scholar
  88. Tsai KW, Lo YH, Liu H, Yeh CY, Chen YZ, Hsu CW, Chen WS. and Wang JH 2018 Linc00659, a long noncoding RNA, acts as novel oncogene in regulating cancer cell growth in colorectal cancer. Mol. Cancer 17 72PubMedPubMedCentralGoogle Scholar
  89. Tuncer HB and Bensan AE 2014 Noncoding RNAs and cancer. Turk. J. Biol. 38 817–28Google Scholar
  90. Van Grembergen O, Bizet M, Eric J, Calonne E, Putmans P, Brohée S, Olsen C, Guo M et al. 2016 Portraying breast cancers with long noncoding RNAs. Sci. Adv. 2 e1600220PubMedPubMedCentralGoogle Scholar
  91. Wang KC and Chang HY 2011 Molecular mechanisms of long noncoding RNAs. Mol. Cell. 43 904–914PubMedPubMedCentralGoogle Scholar
  92. Wang Y, Zhang D, Wu K, Zhao Q, Nie Y and Fan D 2014 Long noncoding RNA MRUL promotes ABCB1 expression in multidrug-resistant gastric cancer cell sublines. Mol. Cell. Biol. 34 3182–3193PubMedPubMedCentralGoogle Scholar
  93. Wu W, Wagner EK, Hao Y, Rao X, Dai H, Han J, Chen J, Storniolo AMV et al. 2016 Tissue-specific co-expression of long non-coding and coding RNAs Associated with breast cancer. Sci. Rep. 6 32731PubMedPubMedCentralGoogle Scholar
  94. Xu ZY, Yu QM, Du YA, Yang LT, Dong RZ, Huang L, Yu PF and Cheng XD 2013 Knockdown of long non-coding RNA HOTAIR suppresses tumor invasion and reverses epithelial-mesenchymal transition in gastric cancer. Int. J. Biol. Sci. 9 587PubMedPubMedCentralGoogle Scholar
  95. Xu S, Sui S, Zhang J, Bai N, Shi Q, Zhang G, Gao S, You Z, et al. 2015 Downregulation of long noncoding RNA MALAT1 induces epithelial-to-mesenchymal transition via the PI3K-AKT pathway in breast cancer. Int. J. Clin. Exp. Pathol. 8 4881PubMedPubMedCentralGoogle Scholar
  96. Xu T, Lin CM, Cheng SQ, Min J, Li L, Meng XM, Huang C, Zhang L et al. 2018 Pathological bases and clinical impact of long noncoding RNAs in prostate cancer: a new budding star. Mol. Cancer 17 103PubMedPubMedCentralGoogle Scholar
  97. Yang F, Bi J, Xue X, Zheng L, Zhi K, Hua J and Fang G 2012 Up‐regulated long non‐coding RNA H19 contributes to proliferation of gastric cancer cells. FEBS J. 279 3159–3165PubMedGoogle Scholar
  98. Yang F, Lyu S, Dong S, Liu Y, Zhang X and Wang O 2016 Expression profile analysis of long noncoding RNA in HER-2-enriched subtype breast cancer by next-generation sequencing and bioinformatics. Onco Targets Ther. 9 761PubMedPubMedCentralGoogle Scholar
  99. Yang X, Duan B and Zhou X 2017 Long non-coding RNA FOXD2-AS1 functions as a tumor promoter in colorectal cancer by regulating EMT and Notch signaling pathway. Eur. Rev. Med. Pharmacol. Sci. 21 3586–3591PubMedGoogle Scholar
  100. Yang Y, Junjie P, Sanjun C and Ma Y 2017 Long non-coding RNAs in colorectal cancer: progression and future directions. J. Cancer 8 3212PubMedPubMedCentralGoogle Scholar
  101. Zhan L, Li J and Wei B 2018 Long non-coding RNAs in ovarian cancer. J. Exp. Clin. Cancer Res. 37 120PubMedPubMedCentralGoogle Scholar
  102. Zhang X, Rice K, Wang Y, Chen W, Zhong Y, Nakayama Y, Zhou Y and Klibanski A 2009 Maternally expressed gene 3 (MEG3) noncoding ribonucleic acid: isoform structure, expression, and functions. Endocrinol. 151 939–947Google Scholar
  103. Zhang K, Luo Z, Zhang Y, Song X, Zhang L, Wu L and Liu J 2017 Long non-coding RNAs as novel biomarkers for breast cancer invasion and metastasis. Oncol. Lett. 14 1895–1904PubMedPubMedCentralGoogle Scholar
  104. Zhao J, Liu Y, Zhang W, Zhou Z, Wu J, Cui P, Zhang Y and Huang G 2015 Long non-coding RNA Linc00152 is involved in cell cycle arrest, apoptosis, epithelial to mesenchymal transition, cell migration and invasion in gastric cancer. Cell Cycle 14 3112–3123PubMedPubMedCentralGoogle Scholar
  105. Zhong Y, Gao D, He S, Shuai C and Peng S 2016 Dysregulated expression of long noncoding RNAs in ovarian cancer. Int. J. Gynecol. Cancer. 26 1564PubMedPubMedCentralGoogle Scholar
  106. Zhou Y, Wang C, Liu X, Wu C and Yin H 2017 Long non-coding RNA HOTAIR enhances radioresistance in MDA-MB231 breast cancer cells. Oncol. Lett. 13 1143–1148PubMedPubMedCentralGoogle Scholar
  107. Zhu Q, Hoong N, Aslanian A, Hara T, Benner C, Heinz S, Miga KH, Ke E, Verma S, Soroczynski J and Yates JR 2018 Heterochromatin-encoded satellite RNAs induce breast cancer. Mol. Cell. 70 842–853PubMedPubMedCentralGoogle Scholar
  108. Zou AE, Ku J, Honda TK, Yu V, Kuo SZ, Zheng H, Xuan Y, Saad MA et al. 2015 Transcriptome sequencing uncovers novel long noncoding and small nucleolar RNAs dysregulated in head and neck squamous cell carcinoma. RNA 21 1122–1134PubMedPubMedCentralGoogle Scholar

Copyright information

© Indian Academy of Sciences 2019

Authors and Affiliations

  1. 1.School of BioSciences and TechnologyVIT UniversityVelloreIndia

Personalised recommendations